ReviewExpert opinion on therapeutic targets2008

New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Di Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.